Martina Rodrigues de Oliveira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Martina Rodrigues de Oliveira has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Bruno Guedes Baldi
Divisao de Pneumologia, Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sâo Paulo, Sâo Paulo, Brazil
3 shared publications - Carlos Roberto Ribeiro Carvalho
Divisao de Pneumologia, Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sâo Paulo, Sâo Paulo, Brazil
3 shared publications - Ellen Caroline Toledo Do Nascimento
Department of Pathology, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil
2 shared publications - Guilherme das Posses Bridi
Divisao de Pneumologia, Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sâo Paulo, Sâo Paulo, Brazil
2 shared publications - Adalberto Sperb Rubin
Hospital Santa Casa de Porto Alegre, Pavilhão Pereira Filho, Porto Alegre (RS) Brasil
1 shared publication - Adriano Massuda
Universidade do Minho, Portugal
1 shared publication
Latest Publications
- Open Access
- 26 March 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (3) , e020291
TeleICU obstetrics: a strategy to decrease maternal mortality in Brazil
Background: Maternal mortality in Brazil remains elevated despite local initiatives. The TeleICU Obstetric (TIO) project was created to assist intensive care units in reference obstetric hospitals. Methods: 25 Brazilian hospitals were selected by the Ministry of Health for the TIO programme, running from April 2022 to May 2024. The programme included teletraining for multidisciplinary teams, teleinterconsultations with specialists and monitoring of maternal health indicators. Training modalities included asynchronous, synchronous and in loco formats. Teleinterconsultations were conducted between hospital professionals and the obstetrics team and intensivists from Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, available 7 days a week. The maternal mortality ratio (MMR) was calculated for the 6 months prior to the project (baseline) and for the 7 months following its implementation. Findings: Median project participation was 7 (6–10) months. Training was completed by 564 professionals (asynchronous), 1707 (synchronous) and 831 (in loco), with a Net Promoter Score of 85 (81–92), 100 (93–100) and 95 (92–100), respectively. Teleinterconsultations assisted 1351 patients across 4556 sessions. 16 hospitals provided full data for analysis. MMR reduced significantly by 45% (p<0.05), from 190 (63–346) pre-intervention to 104 (55–213) during implementation. Interpretation: The TIO project is feasible and scalable for other economically disadvantaged countries facing similar challenges to reducing maternal mortality.
- 26 March 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (3) , e020291
Open AccessTeleICU obstetrics: a strategy to decrease maternal mortality in Brazil
Background: Maternal mortality in Brazil remains elevated despite local initiatives. The TeleICU Obstetric (TIO) project was created to assist intensive care units in reference obstetric hospitals. Methods: 25 Brazilian hospitals were selected by the Ministry of Health for the TIO programme, running from April 2022 to May 2024. The programme included teletraining for multidisciplinary teams, teleinterconsultations with specialists and monitoring of maternal health indicators. Training modalities included asynchronous, synchronous and in loco formats. Teleinterconsultations were conducted between hospital professionals and the obstetrics team and intensivists from Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, available 7 days a week. The maternal mortality ratio (MMR) was calculated for the 6 months prior to the project (baseline) and for the 7 months following its implementation. Findings: Median project participation was 7 (6–10) months. Training was completed by 564 professionals (asynchronous), 1707 (synchronous) and 831 (in loco), with a Net Promoter Score of 85 (81–92), 100 (93–100) and 95 (92–100), respectively. Teleinterconsultations assisted 1351 patients across 4556 sessions. 16 hospitals provided full data for analysis. MMR reduced significantly by 45% (p<0.05), from 190 (63–346) pre-intervention to 104 (55–213) during implementation. Interpretation: The TIO project is feasible and scalable for other economically disadvantaged countries facing similar challenges to reducing maternal mortality.
- Open Access
- 23 January 2025
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 51 (1) , e20240378
Brazilian Thoracic Association recommendations for the management of lymphangioleiomyomatosis
Lymphangioleiomyomatosis (LAM) is a rare disease, characterized as a low-grade neoplasm with metastatic potential that mainly affects women of reproductive age, in which there is proliferation of atypical smooth muscle cells (LAM cells) and formation of diffuse pulmonary cysts. It can occur in a sporadic form or in combination with tuberous sclerosis complex. In recent decades, a number of advances have been made in the understanding of the pathophysiology and management of LAM, leading to improvements in its prognosis: identification of the main genetic aspects and the role of the mechanistic target of rapamycin (mTOR) pathway; relationship with hormonal factors, mainly estrogen; characterization of pulmonary and extrapulmonary manifestations in imaging studies; identification and importance in the diagnosis of VEGF-D; a systematic diagnostic approach, often without the need for lung biopsy; use of and indications for the use of mTOR inhibitors, mainly sirolimus, for pulmonary and extrapulmonary manifestations; pulmonary rehabilitation and the management of complications such as pneumothorax and chylothorax; and the role of and indications for lung transplantation. To date, no Brazilian recommendations for a comprehensive approach to the disease have been published. This document is the result of a non-systematic review of the literature, carried out by 12 pulmonologists, a radiologist, and a pathologist, which aims to provide an update of the most important topics related to LAM, mainly to its diagnosis, treatment, and follow-up, including practical and multidisciplinary aspects of its management.
- 23 January 2025
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 51 (1) , e20240378
Open AccessBrazilian Thoracic Association recommendations for the management of lymphangioleiomyomatosis
Lymphangioleiomyomatosis (LAM) is a rare disease, characterized as a low-grade neoplasm with metastatic potential that mainly affects women of reproductive age, in which there is proliferation of atypical smooth muscle cells (LAM cells) and formation of diffuse pulmonary cysts. It can occur in a sporadic form or in combination with tuberous sclerosis complex. In recent decades, a number of advances have been made in the understanding of the pathophysiology and management of LAM, leading to improvements in its prognosis: identification of the main genetic aspects and the role of the mechanistic target of rapamycin (mTOR) pathway; relationship with hormonal factors, mainly estrogen; characterization of pulmonary and extrapulmonary manifestations in imaging studies; identification and importance in the diagnosis of VEGF-D; a systematic diagnostic approach, often without the need for lung biopsy; use of and indications for the use of mTOR inhibitors, mainly sirolimus, for pulmonary and extrapulmonary manifestations; pulmonary rehabilitation and the management of complications such as pneumothorax and chylothorax; and the role of and indications for lung transplantation. To date, no Brazilian recommendations for a comprehensive approach to the disease have been published. This document is the result of a non-systematic review of the literature, carried out by 12 pulmonologists, a radiologist, and a pathologist, which aims to provide an update of the most important topics related to LAM, mainly to its diagnosis, treatment, and follow-up, including practical and multidisciplinary aspects of its management.
- Open Access
- 10 March 2024
- Published by Taylor & Francis in Pulmonology
- Vol. 30 (2) , 195-197
Thoracic endometriosis presenting as diffuse cystic lung disease: a rare case report
- 10 March 2024
- Published by Taylor & Francis in Pulmonology
- Vol. 30 (2) , 195-197
Open AccessThoracic endometriosis presenting as diffuse cystic lung disease: a rare case report
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A6341
Thoracic Endometriosis Presented as Diffuse Cystic Lung Disease: A Rare Case Report
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A6341
Thoracic Endometriosis Presented as Diffuse Cystic Lung Disease: A Rare Case Report